Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Saga in strategic partnership with NatWest to deliver over-50s savings products

(Sharecast News) - Saga said on Monday that it has entered into a seven-year partnership with NatWest's banking-as-a-service business, NatWest Boxed, to deliver "innovative" savings products for people over 50. It said the long-term strategic partnership combines NatWest's scale and Boxed's platform, operational and compliance expertise with Saga's "extensive insight and experience" in the market for people over 50.

Saga said the partnership will enable it to expand its range of financial services, initially through an improved instant access savings product, with additional savings and other financial services products expected in due course.

The new partnership will also facilitate an extension of Saga Money's offer, building on the company's belief that people over 50 across the UK deserve a suite of products that are designed to cater for their needs.

The new instant access savings product, developed through the NatWest partnership, will replace Saga's current Goldman Sachs instant access savings product for new customers and will be launched later this year.

Jerry Toher, chief executive of Saga Money, said: "As the UK's specialist in providing products for people over 50, this launch is an exciting next step in enhancing our Money offer. This will further strengthen our position in providing competitive and flexible savings products, ensuring that Saga remains the most-trusted brand for people over 50 in the UK.

"I look forward to working with NatWest Boxed as we continue our strategy of delivering great value products to support customers with their savings goals."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.